Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Xenon Pharmaceuticals Inc XENE

Xenon Pharmaceuticals Inc. is a Canada-based neuroscience-focused biopharmaceutical company committed to discovering, developing, and commercializing therapeutics to improve the lives of people living with neurological and psychiatric disorders. The Company is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. Azetukalner, the... see more

Recent & Breaking News (NDAQ:XENE)

Xenon Pharmaceuticals to Present at the Wells Fargo 2023 Healthcare Conference

GlobeNewswire August 31, 2023

Xenon Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update

GlobeNewswire August 9, 2023

Xenon Pharmaceuticals Expands Leadership on its Board of Directors with Appointments of Gillian M. Cannon and Justin Gover

GlobeNewswire August 8, 2023

Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Second Quarter 2023 Financial Results and Provide Corporate Update

GlobeNewswire August 2, 2023

Xenon Pharmaceuticals to Present at the Goldman Sachs 44th Annual Global Healthcare Conference

GlobeNewswire June 6, 2023

Xenon Pharmaceuticals to Present at the 2023 Jefferies Healthcare Conference

GlobeNewswire May 31, 2023

Xenon Pharmaceuticals to Present at the 2023 RBC Capital Markets Global Healthcare Conference

GlobeNewswire May 11, 2023

Xenon Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update

GlobeNewswire May 9, 2023

Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2023

GlobeNewswire May 3, 2023

Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2023 Financial Results and Provide Corporate Update

GlobeNewswire May 2, 2023

Xenon Pharmaceuticals Showcases Its XEN1101 Epilepsy Program at the 2023 American Academy of Neurology (AAN) Annual Meeting

GlobeNewswire April 24, 2023

Xenon Pharmaceuticals to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference

GlobeNewswire April 21, 2023

Xenon Pharmaceuticals to Present at the 22nd Annual Needham Virtual Healthcare Conference

GlobeNewswire April 18, 2023

Xenon Pharmaceuticals to Present at the Stifel 2023 CNS Days

GlobeNewswire March 22, 2023

Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

GlobeNewswire March 1, 2023

Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update

GlobeNewswire February 22, 2023

Xenon Pharmaceuticals to Present at the SVB Securities Global Biopharma Conference

GlobeNewswire February 8, 2023

Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2023

GlobeNewswire January 9, 2023

Xenon Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference

GlobeNewswire January 4, 2023

Xenon Pharmaceuticals Provides Updates on Proprietary Neurology Pipeline Programs at the Annual Meeting of the American Epilepsy Society (AES 2022)

GlobeNewswire December 2, 2022